Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes

Angela M Valverde1, Deborah J Burks, Isabel Fabregat

  • 1Instituto de Bioquímica/Departamento de Bioquímica y Biología Molecular II, Centro Mixto CSIC/UCM, Facultad de Farmacia, Universidad Complutense, Madrid, Spain. valverde@farm.ucm.es

Diabetes
|August 28, 2003
PubMed

Insights

Insulin receptor substrate-2 (IRS-2) is essential for liver insulin signaling, regulating glucose metabolism and gene expression. Its absence impairs insulin

Area of Science:

  • Hepatology and Molecular Endocrinology
  • Cellular Metabolism
  • Signal Transduction Pathways

Background:

  • Insulin resistance is a major metabolic disorder.
  • Insulin receptor substrate proteins mediate insulin signaling.
  • The specific role of IRS-2 in hepatic insulin action requires further elucidation.

Purpose of the Study:

  • To determine the role of IRS-2 in hepatic insulin signaling.
  • To investigate IRS-2's impact on glucose metabolism in hepatocytes.
  • To assess IRS-2's contribution to insulin resistance in the liver.

Main Methods:

  • Generation of IRS-2 knockout, heterozygous, and wild-type mouse primary hepatocytes.
  • Insulin stimulation assays to measure PI 3-kinase activity, Akt, GSK-3, Foxo1, and PKC activation.
  • Assessment of glycogen synthase activity and gluconeogenic gene expression (PEPCK, G6Pase).
  • Reconstitution of IRS-2 signaling using adenoviral vectors.

Main Results:

  • IRS-2 deficiency significantly reduced insulin-induced PI 3-kinase activity and downstream signaling.
  • Absence of IRS-2 abolished insulin-stimulated glycogen synthesis.
  • IRS-2-deficient hepatocytes failed to suppress gluconeogenic gene expression in response to insulin.
  • Reconstitution of IRS-2 restored insulin signaling, glycogen synthesis, and suppression of gluconeogenesis.

Conclusions:

  • IRS-2 is indispensable for functional insulin signaling in hepatocytes.
  • IRS-2 plays a critical role in regulating hepatic glucose production and glycogen synthesis.
  • Targeting IRS-2 may offer therapeutic strategies for insulin resistance and type 2 diabetes.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...